Relationship between the status of phospholipase A2 receptor and prognosis of idiopathic membranous nephropathy
Authors:
- 21 June 2019
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 25 (2) , 144-149
Abstract
Aim: Serum levels of phospholipase A2 receptor antibody (PLA2R; SAb) and glomerular deposits of PLA2R antigen (GAg) have been detected in patients with idiopathic membranous nephropathy (IMN). However, the correlation between these immunologic factors and their associations with the status and prognosis of IMN remain uncertain.Methods: Fifty‐one patients with biopsy‐proven IMN diagnosed between March of 2015 and December of 2016 were enrolled in this study. All the patients were followed until March of 2017.We used enzyme‐linked immunosorbent assay and immunofluorescence to measure the SAb and GAg, respectively.Results: The positive rate of GAg was significantly higher than SAb in patients with IMN (88.24 vs 66.77%, P = 0.017). Compared with SAb− patients, SAb+ patients had a higher baseline proteinuria (6.21 vs 3.40 g/24 h), lower serum albumin (22.49 ± 6.59 vs 29.09 ± 7.40 g/L) and poorer renal function (88.96 ± 21.17 vs 107.25 ± 20.04 mL/min per 1.73 m2), as well as a higher renal IgG4 level (P < 0.05). A comparison of SAb+/GAg+ and SAb−/GAg+ tissues yielded similar results (P < 0.01). Regarding prognosis, SAb− patients had a higher rate of complete remission after immunosuppressive treatment than SAb+ patients (P = 0.042).Conclusion: The disease status and prognosis correlated more closely with the SAb than with the GAg in our cohort of patients with IMN. Furthermore, SAb+ patients had more severe clinical symptoms and a worse prognosis, which was probably associated with increased IgG4 deposition.Keywords
This publication has 15 references indexed in Scilit:
- Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyJournal of the American Society of Nephrology, 2015
- Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous NephropathyTransplantation, 2015
- Pathophysiological advances in membranous nephropathy: time for a shift in patient's careThe Lancet, 2015
- Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous NephropathyPLOS ONE, 2013
- Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2012
- Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathyKidney International, 2012
- Anti-Phospholipase A2 Receptor Antibody in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- Antigen Identification in Membranous Nephropathy Moves toward Targeted Monitoring and New TherapyJournal of the American Society of Nephrology, 2010
- Controversies in the treatment of idiopathic membranous nephropathyNature Reviews Nephrology, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009